M. Filipan-Litvic´ et al. / Tetrahedron 64 (2008) 10912–10918
10917
with Kieselgel 60254. Melting points were determined using a Bu¨chi
B540 instrument. Elemental analyses were performed at the Cen-
microwave oven (180 ꢀC and power of 1000 W) for the times in-
dicated in Table 3. The product was extracted with dichloro-
methane (3ꢁ20 mL) and analyzed by HPLC to determine the
conversion of the reaction.
ˇ
´
tral Analytical Service (CAS) at RuCer Boskovic Institute. Microwave
irradiation promoted reactions were carried out in Milestone MLS-
1200 pyro oven. All chemicals and solvents were purchased from
Aldrich and Merck-Darmstadt. The 1,4-DHPs have been prepared
according to modified Hantzsch methods.20g,18t,29–31 All products of
aromatization are known in the literature and were fully charac-
terized by a comparison with authentic samples (melting point)
and their NMR (1H, 13C) and IR spectra.20g
4.5. Charge-transfer probes
To a solution of corresponding 1,4-DHPs in dry dichloro-
methane27,28 metallic halide was added (TaCl5, NbCl5, HfCl4, ZrCl4)
at once. The suspension was stirred at room temperature to furnish
characteristic coloration. The same test was performed under ul-
trasound sonification to yield more intensive colors in shorter time
(Fig. 2).
4.2. Reaction of 2,6-dimethyl-3,5-dimethoxy-carbonyl-1,4-
dihydropyridine (4) with NbCl5 in acetonitrile at room
temperature
Acknowledgements
To a solution of 1,4-DHP (12, 6 mmol; 1,86 g) in acetonitrile
(30 mL) at room temperature, NbCl5 (6 mmol, 1.62 g) was added at
once. The resulting suspension was stirred at room temperature for
18 days. After that to the reaction mixture were added water
(30 mL) and dichloromethane (30 mL). The phases were separated
and the aqueous phase was additionally extracted with dichloro-
methane (3ꢁ20 mL). The combined organic layers were dried over
Na2SO4, filtered, and evaporated to dryness. The residue was trit-
urated with diisopropylether (50 mL), stirred at room temperature
for 24 h, and filtered. The brown crystals were washed with two
portions of diisopropylether (2ꢁ5 mL). The mother liquor was
evaporated to dryness and the residue was suspended in n-hexane
(50 mL) and stirred at room temperature for 12 h. The inorganic
crystals were filtered and washed with n-hexane (2ꢁ5 mL). The
organic extracts were gathered and evaporated to dryness. The oily
residue was purified by PTLC on silica gel plates using dichloro-
methane as eluent. The fraction with Rf¼0.55 was extracted with
dichloromethane (50 mL) and evaporated to dryness to give 6;
The authors wish to express their gratitude to the Belupo
Pharmaceuticals Inc. for financial support of this research.
References and notes
1. Hantzsch, A. Chem. Ber. 1881, 14, 1637–1638.
2. (a) Gru¨ n, G.; Fleckenstein, A. Arzneim.-Forsch. (Drug Res.) 1972, 22, 334–344; (b)
Bossert, F.; Meyer, H.; Wehinger, E. Angew. Chem. 1981, 93, 755–763; (c) Janis, R.
A.; Triggle, D. J. J. Med. Chem. 1983, 26, 775–785.
3. Berkels, B.; Roesen, R.; Dhein, S.; Fricke, U.; Klaus, W. Cardiovasc. Drug Rev. 1999,
17, 179–186.
4. Tsuruo, T.; Iida, H.; Nojiri, M.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1983, 43,
2905–2910.
5. Chapman, R. W.; Danko, G.; Siegels, M. I. Pharmacology 1984, 29, 282–291.
6. Malaise, W. J.; Mathias, P. C. F. Diabetologia 1985, 28, 153–156.
7. Krauze, A.; Germane, S.; Eberlins, O.; Sturms, I.; Klusa, V.; Duburs, G. Eur. J. Med.
Chem. 1999, 34, 301–310.
8. Peri, R.; Padmanabhan, S.; Singh, S.; Rutledge, A.; Triggle, D. J. J. Med. Chem.
2000, 43, 2906–2914.
9. Zhou, X.; Zhang, L.; Tseng, E.; Scott-Ramsay, E.; Schentag, J. J.; Coburn, R. A.;
Morris, M. E. Drug Metab. Dispos. 2005, 33, 321–328.
50 mg (5.2%) as yellow oil. IR (KBr):
1496, 1451, 1440, 1332, 1283, 1260, 1185, 1074, 1039, 1029,
1016 cmꢂ1; 1H NMR (CDCl3):
¼3.81 (t, 3H, OCH3), 6.45 (d, 1H, CH,
n
¼3028, 2991, 2947, 1698, 1679,
10. The Merck Index,12th ed.;Merck Research Laboratories: New Jersey, NJ,1996; p 1121.
11. Iwanami, M.; Shibanuma, T.; Fujimoto, M.; Kawai, R.; Tamazawa, K.; Takenaka,
T.; Takahashi, K.; Murakami, M. Chem. Pharm. Bull. 1979, 27, 1426–1440.
12. Bostro¨m, S. L.; Ljung, B.; Mårdh, S.; Forsen, S.; Thulin, E. Nature 1981, 292,
777–778.
13. Arrowsmith, J. E.; Campbell, S. F.; Cross, P. E.; Stubbs, J. K.; Burges, R. A.;
Gardiner, D. G.; Blackburn, K. J. J. Med. Chem. 1986, 29, 1696–1702.
14. Bo¨cker, R. H.; Guengerich, F. P. J. Med. Chem. 1986, 28, 1596–1603.
15. Bischhoff, H.; Angerbauer, R.; Bender, J.; Bischoff, E.; Faggiotto, A.; Petzinna, D.;
Pfitzner, J.; Porter, M. C.; Schmidt, D.; Thomas, G. Atherosclerosis 1997, 135,
119–130.
d
J¼16.0 Hz), 7.38–7.39 (m, 3H, arom.), 7.51–7.53 (m, 2H, arom.), 7.70
(d, 1H, CH, J¼16.0 Hz); 13C NMR (CDCl3):
¼51.6, 117.8, 128.0, 128.8,
d
130.2, 134.3, 144.8, 167.3. Anal. Calcd for C10H10O2: C, 74.06; H, 6.21.
Found: C, 74.2; H, 6.4.
4.3. General procedure for the aromatization of 1,4-DHPs by
VOCl3 in dichloromethane at room temperature
16. Kudo, S.; Okumura, H.; Miyamoto, G.; Ishizaki, T. Drug Metab. Dispos. 1999, 27,
303–308.
17. Memarian, H. R.; Abdoli-Senejani, M.; Tangestaninejad, S. J. Iran. Chem. Soc.
2006, 3, 285–292.
To a solution of 1,4-DHP derivatives (4, 8–28, 1 mmol) in
dichloromethane (10 mL) VOCl3 was added at once (2.1 mL,
2.1 mmol, 1 M solution in dichloromethane). The reaction mixture
was stirred at room temperature for the time indicated in Table 2.
After that to the reaction mixture was added water (15 mL) and the
pH of water layer was adjusted to 7 with solid NaHCO3. The phases
were separated and the aqueous phase was additionally extracted
with dichloromethane (2ꢁ10 mL). The combined organic layers
were dried over Na2SO4, filtered, and evaporated to dryness. The
crude products were chromatographed on silica gel column eluting
with dichloromethane/ethyl acetate (9:1) to give products of purity
>99%.
18. (a) Khadilkar, B.; Jaisinghani, H.; Khare, A. Ind. J. Chem. 1998, 37B, 817–818; (b)
Meyer, H.; Wehinger, E.; Bossert, F.; Scherling, D. Arzneim.-Forsch. (Drug Res.)
1983, 33, 106–112; (c) Sugiyama, N.; Kubota, K.; Inouye, G. Bull. Chem. Soc. Jpn.
1964, 37, 637–639; (d) Pfister, J. R. Synthesis 1990, 689–690; (e) Vanden Eynde,
J. J.; D’Ozario, R.; Van Haverbeke, Y. Tetrahedron 1994, 50, 2479–2484; (f)
Choudary, B. M.; Valli, V. L. K.; Durga Prasad, A. Synth. Commun. 1991, 21, 2007–
2013; (g) Karami, B.; Montazerozohori, M.; Habibi, M. H.; Zolfigol, M. A. Het-
erocycl. Commun. 2006, 11, 513–516; (h) Memarian, H. R.; Sadeghi, M. M.;
Momeni, A. R. Synth. Commun. 2001, 31, 2241–2244; (i) Vanden Eynde, J. J.;
Delfosse, F.; Mayence, A.; Van Haverbeke, Y. Tetrahedron 1995, 51, 6511–6516; (j)
Katsuyama, I.; Ogawa, S.; Nakamura, H.; Yamaguchi, Y.; Funabiki, K.; Matsui, M.;
Muramatsu, H.; Shibata, K. Heterocycles 1998, 48, 779–785; (k) Kuno, A.; Sakai,
H.; Ohkubo, M.; Takasugi, H. Chem. Pharm. Bull. 1993, 41, 156–162; (l) Kuno, A.;
Sakai, H.; Ohkubo, M.; Takasugi, H. Chem. Pharm. Bull. 1993, 41, 163–170; (m)
Bagley, M. C.; Lubinu, M. C. Synthesis 2006, 1283–1288; (n) Alvarez, C.; Delgado,
F.; Garcı´a, O.; Medina, S.; Ma´rquez, C. Synth. Commun. 1991, 21, 619–624; (o)
´
´
Delgado, F.; Alvarez, C.; Garcıa, O.; Penieres, G.; Marquez, C. Synth. Commun.
1991, 21, 2137–2141; (p) Heravi, M. M.; ShMoosavi, F. S.; ShBeheshtiha, Y.;
Ghassemzadeh, M. Heterocycl. Commun. 2004, 10, 415–418; (q) Varma, R. S.;
Kumar, D. Tetrahedron Lett. 1999, 40, 21–24; (r) Lu, J.; Bai, Y.; Wang, Z.; Yang, B.;
Li, W. Synth. Commun. 2001, 31, 2625–2630; (s) Lu, J.; Bai, Y.-J.; Yang, B.-Q.; Ma,
4.4. General procedure for the aromatization of 1,4-DHPs
with metallic oxides under microwave irradiation
To a solution of 1,4-DHP 4 (1.50 g, 5 mmol) in dichloromethane
(20 mL) was added the corresponding metallic oxide (10 mmol,
V2O5; 5 mmol, MoO3; 10 mmol, CeO2; 5 mmol, HfO2; 5 mmol,
GeO2). After stirring at room temperature for 15 min, the suspen-
sion was evaporated to dryness and dried in vacuum to constant
weight. Thus obtained adsorbed 1,4-DHP was irradiated in
´
H.-R. Chin. J. Org. Chem. 2000, 20, 514–517; (t) Litvic, M.; Cepanec, I.; Filipan, M.;
ˇ ´
ˇ
´
´
Kos, K.; Bartolincic, A.; Druskovic, V.; Tibi, M. M.; Vinkovic, V. Heterocycles 2005,
´
´
´
65, 23–35; (u) Filipan-Litvic, M.; Litvic, M.; Cepanec, I.; Vinkovic, V. ARKIVOC
2008, xi, 96–103.
19. (a) Mohr, E.; Schneider, W. J. Prakt. Chem. 1904, 69, 245–264; (b) Kro¨hnke, F.;
Ahrenhok, G. M.; Gross, K. F. J. Prakt. Chem. 1960, 11, 256–264; (c) Go¨rlitzer, K.;
Buß, D. Arch. Pharm. (Weinheim, Ger.) 1981, 314, 949–954; (d) Zolfigol, M. A.;